Field of Study USA: Medical Sciences

Ravikumar Majeti

Dr. Ravikumar Majeti (cited as Kumar MNVR) is a distinguished university research professor, assistant vice president for interdisciplinary research, and founding director of the Center for Convergent Bioscience and Medicine at The University of Alabama, Tuscaloosa. He is internationally recognized as a leading authority on nanomedicine, with a research portfolio spanning drug delivery, therapeutic repurposing, and personalized treatment strategies for chronic diseases.

Dr. Majeti’s academic journey began with a BSc in physical sciences from A.J. Kalasala, Machilipatnam, Andhra Pradesh, followed by an MSc in applied chemistry from SGSITS, Indore, Madhya Pradesh, and a PhD in drug delivery from IIT Roorkee.

Prior to his appointment at Alabama, he held academic positions at Texas A&M University, College Station; the University of Strathclyde, Glasgow, UK; and the National Institute of Pharmaceutical Education and Research, Mohali, India.

Dr. Majeti’s research focuses on the mechanisms of transcytosis at the intestine–blood barrier leading to the development of tunable, biodegradable nanoparticles for the oral delivery of poorly bioavailable small-molecule drugs and drug-like compounds (https://sites.ua.edu/dreamlab/). His patented delivery platforms have shown substantial efficacy in preclinical models of diabetic complications, lupus, and acute kidney injury, offering precision therapies where standard treatments are inadequate or unavailable.

As a dedicated mentor and scientific leader, Dr. Majeti has fostered international collaborations, guided the growth of early-career researchers, and spearheaded high-impact interdisciplinary programs supported by leading global funding agencies. His work has significantly advanced both the fundamental science and clinical translation of next-generation drug delivery systems.

For his Fulbright-Nehru project, Dr. Majeti is investigating the therapeutic promise of plant-based polyphenolic nutraceuticals through interdisciplinary collaboration at the crossroads of biomaterials and medicine. Focusing on oral bioavailability, a central challenge in the field, he is designing nano-engineered delivery systems to improve the efficacy of compounds such as Urolithin A. By integrating fundamental research with applied testing in models of chronic metabolic diseases, Dr. Majeti seeks to bridge laboratory innovation with clinical relevance. His work aims to realize the untapped potential of nutraceuticals and advances them as viable tools in the prevention and management of modern chronic health conditions.

Aditya Santoki

Mr. Aditya Santoki graduated from Duke University in 2021 cum laude as a Chemistry major. While at Duke, Mr. Santoki was a neurobiology researcher in Dr. Cagla Eroglu’s lab and investigated the rate of neuronal cell death in Huntington’s Disease. Having self-studied computer science in college, Mr. Santoki designed a program that would characterize the rate of neuronal cell delineated by brain region, eventually seeing his work published as a second-author in Cell Reports. Additionally, while at Duke, Mr. Santoki was also deeply involved in health policy research. After having taken an Introduction to the U.S. Healthcare System class with Dr. Nathan Boucher, Mr. Santoki designed an independent project to assess the determinants of vaccine hesitancy in Durham County. As a part of his project, Mr. Santoki interviewed physicians and patients to find that even brief physician-led conversations on the safety and efficacy of vaccines could drastically reduce vaccine-hesitancy. Most importantly, Mr. Santoki learned how effective physician-led conversations on treatment could drastically affect patient care. This sparked Mr. Santoki’s interest in understanding how cost of care conversations on a national scale could reduce financial toxicity for patients. Since then, Mr. Santoki has published his work on vaccine hesitancy as a first-author in the North Carolina Medical Journal (NCMJ).

After graduating from Duke University, Mr. Santoki has been working as a research fellow at the National Institutes of Health (NIH). At the NIH, Mr. Santoki routinely shadows neurooncologists having cost of care discussions with terminal cancer patients. Through these conversations Mr. Santoki has seen how patients can make much more informed decisions about their care and plan personalized and affordable courses of treatment. Moreover, Mr. Santoki has also been exposed to the potential of personalized medicine while working in Dr. Claire Le Pichon’s lab. While in the Le Pichon lab, Mr. Santoki has been assisting a project characterizing a novel mouse model of a rare form of ALS. Mr. Santoki has also been working part-time at a biopharma venture capital firm investigating drug pricing for rare disease therapeutics. Both these experiences have sparked Mr. Santoki’s interest in translating personalized therapeutics and ensuring they are affordable for patients. In his free time Mr. Santoki enjoys reading, weightlifting, and running.

For his Fulbright-Nehru project, Mr. Santoki is travelling to medical centers throughout Kerala to survey oncologists treating cancer patients. He is assessing physician awareness of treatment costs and low-cost alternatives. If time permits, Mr. Santoki aims to assess patients’ willingness to pay for genomic assays to define need for adjuvant chemotherapy for breast cancer. He is also estimating the proportion of patients who get colitis after starting immunotherapy. These analyses will help physicians determine whether cost conversations on preventative treatments can prevent future expenses.

Rishabh Jain

Mr. Rishabh Jain graduated magna cum laude with Departmental Distinction in Biomedical Engineering from Duke University, where he was elected, in his junior year, to Tau Beta Pi. His research interests have spanned diverse fields, from bioengineering to technology policy to rural healthcare access. His senior thesis work as a Pratt Research Fellow consisted of designing a self-assembling, peptide-based supramolecular vaccine for Zika virus, for which he received the Howard G. Clark Award for Excellence in Research. He has also conducted research on injectable hydrogels for tissue repair after stroke as a Huang Fellow and has published on the pitfalls of thermal facial recognition during the COVID-19 pandemic in the Journal of Law and the Biosciences as a Bass Connections Research Fellow.

Mr. Jain is a contributor to the American Academy of Ophthalmology’s Editor’s Choice section and authored two chapters in an upcoming book on the ocular manifestations of systemic disease. He spent a summer interning at a CAR-T cell company and authoring an investment thesis on cell and gene therapy for a biotechnology-focused venture capital firm.

On campus, Mr. Jain served as Co-Founder and Co-President of the Duke chapter of Remote Area Medical (RAM), a national nonprofit that organizes free pop-up clinics to provide medical, dental, and vision care. With RAM, he led undergraduates and graduate students in multi-dimensional service, research, and advocacy efforts to improve healthcare access for underserved communities, culminating in the deployment of the first RAM clinic in North Carolina.

In his free time, Mr. Jain loves to cook and try new dishes. In 2019, he founded The Black Tile, a pop-up supper club where he served four-course tasting menus to six Duke students at a time. By donating profits to the local food bank, he has been able to provide almost 6000 meals to those in need. He also volunteered with Root Causes, an organization that delivers free, healthy food to food-insecure families.

India has the highest disease burden of uncorrected refractive error (URE) in the world, as measured by disability-adjusted life years. Refractive surgery has been able to vastly improve vision in patients with URE, but there are crucial decisions around the type and parameters of these surgeries that influence patient outcomes and affect postoperative complications. Mr. Jain’s Fulbright-Nehru project is focused on the use of artificial intelligence in refractive surgery, applying deep learning algorithms to the Indian population.

Vineeth Vaidyula

Vineeth Vaidyula is a graduate of the Honors College at Virginia Commonwealth University (VCU) where he majored in biology with a minor in chemistry. In his time at VCU, he explored his interests in public health and medically underserved populations. Passionate about refugee resettlement and immigration advocacy, Vineeth has worked with local resettlement agencies and anti-detention groups as healthcare mentor, youth tutor, public benefits assistant, and detention hotline volunteer. He has also directed the Richmond Refugee Health Partners student volunteer program, an initiative he founded to: address the unmet health advocacy needs of Richmond-based refugees; and improve the cross-cultural, person-centered-care abilities of pre-health undergraduate students at VCU. Moreover, he has served as the president of Students Together Assisting Refugees at VCU (STAR@VCU), an organization he founded which focuses on campus-wide awareness campaigns on migrant issues.

He has also been significantly involved in qualitative and quantitative research, including population-based research and wet-lab virology research. Vineeth’s long-term career goal is to be a physician-advocate, serving the culturally diverse U.S. community that raised him. After completing his Fulbright-Nehru stint, Vineeth is set to matriculate from the Icahn School of Medicine at Mount Sinai.

Vineeth’s Fulbright-Nehru project is studying the Hyderabad vitiligo population using survey instruments, with a focus on investigating how social class impacts the prevalence of the condition and the quality of life of the vitiligo patients. Vineeth hopes that his research in India will help him become globally informed about the social attitudes and structural disparities associated with illness that exist within different sociocultural groups so that he can better serve the diversity of U.S. patients.

Sriram Palepu

Sriram Palepu is a medical student with an interest in identifying and addressing healthcare disparities in South Asia. He completed his undergraduate studies from The University of Texas at Austin where he studied the heavy-metal contamination of the Godavari River. He is now a student of the University of Pennsylvania’s Perelman School of Medicine. He has specific interests in HIV dermatology, gender-affirming care, and environmental health, and hopes to work in India throughout his career.

Sriram is pursuing his Fulbright-Nehru research at Mitr Clinic in Hyderabad in order to understand: the social and health history of trans, or hijra, communities in Hyderabad in terms of substance use and mental health; the extent to which trans individuals are currently satisfied with their external gender presentation; and the attitudes toward the importance of and accessibility of bodily and facial aesthetic procedures in affirming gender identity.

Rachel Jones

Rachel Jones graduated recently from Stony Brook University with a bachelor’s degree in biology, alongside a minor in international and South Asian studies. For the past three years, due to her interest in clinical research, she has been working in an orthopedics lab as a research assistant. Four of Rachel’s works have been published in indexed journals. She also received the URECA (Undergraduate Research and Creative Activities) Summer Fellowship in 2022 which enabled her to carry out full-time faculty-mentored research for 10 weeks. Besides, she has served as a research mentor to underclassmen pursuing guided research of their own. Rachel has also presented her findings twice at the annual spring symposium of Stony Brook University. Her interest in South Asian studies led her to establish her presence in the Mattoo Center for India Studies at Stony Brook. In addition to volunteering at the center and helping with hosting events, she served as a teaching assistant for Indian civilization and linguistic classes. She also received the Vineeth Johnsingh Memorial Scholarship in 2022 for demonstrating outstanding academic potential and promise to foster a better understanding of the Indian civilization.

Rachel’s Fulbright-Nehru research project is studying the socioeconomic impact of parental cancer on resilience in Indian children. While the socioeconomic impact of cancer diagnosis on an adult is well documented, there is little literature on the effect of parental cancer on a child’s development. With India’s rise in cancer burden and rapid increase in population, Rachel is conducting her project in the state of Kerala under the guidance of oncologist, Dr. Aju Mathew. The goal of the project is to extend the findings of this unique study and formulate social interventions to alleviate the effects of parental cancer on children.

Nikhila Raol

Dr. Nikhila Raol is currently an associate professor of otolaryngology-head and neck surgery and pediatrics at Emory University in Atlanta, Georgia. She practices pediatric otolaryngology, with a focus on pediatric feeding and sleep disorders; she also trains residents and fellows. Dr. Raol received her medical degree from the University of Texas Southwestern Medical School in Dallas and her master’s degree in public health from the Harvard T. H. Chan School of Public Health in Boston, Massachusetts. Her research primarily focuses on the management of pediatric feeding disorder, with an emphasis on the healthcare burden associated with the condition; she is also looking into the prevention of conversion of acute pediatric feeding disorder to chronic pediatric feeding disorder. Besides, she is involved in research on treatment of refractory obstructive sleep apnea and serves as the site principal investigator for the National Institutes of Health-funded study looking at cognitive outcomes in children with Trisomy 21 undergoing upper-airway stimulation for obstructive sleep apnea. In addition to the National Institutes of Health, her research has been funded by the American Society of Pediatric Otolaryngology, the Centers for Disease Control and Prevention, and the Marcus Foundation. Dr. Raol has published articles in several leading otolaryngology journals, including JAMA Otolaryngology, Journal of Otolaryngology – Head and Neck Surgery, and The Laryngoscope.

Dr. Raol’s Fulbright-Nehru project is evaluating the role of ankyloglossia, or tongue tie, in the successful maintenance of breastfeeding in Telangana, India. As part of her research, she is conducting observational field studies and interviews with mothers and clinicians who manage mother–infant dyads. Apart from contributing to scholarship on strategies for successful maintenance of breastfeeding, this research will contribute to the development of evidence-based breastfeeding recommendations worldwide.

Yash Deo

The American Psychological Association defines depression as a deep-seated illness marked by sadness and loss of interest in activities. Its impact was deeply felt by Yash Deo when his grandfather was diagnosed with Parkinson’s disease. Yash then played a significant role in his grandfather’s care, taking on daily responsibilities such as bathing him, changing his clothes, and cooking for him. This experience piqued Yash’s interest in the psyche/neuro side of science, prompting him to take a psychology course in high school. There, he was introduced to concepts like neuroplasticity, which reshaped his understanding of the brain’s adaptability quotient. Motivated by these insights, he pursued a bachelor’s degree in neuroscience and worked in Dr. Matthew Cooper’s behavioral neuroscience lab. His studies and lab work deepened his knowledge of the neurobiological mechanisms behind disorders like depression. Outside of the classroom, Yash was active in the neuroscience community at the University of Tennessee, serving as a neuroscience ambassador and holding leadership roles in several university neuroscience organizations. He developed key organizational and team-building skills and launched the Neuro-Tools Series, providing practical neuroscience-based tools on topics such as sleep, focus, and motivation. These experiences have led Yash to aspire to a career in interventional psychiatry, where he aims to use specialized neuromodulatory techniques like transcranial direct current stimulation (tDCS) to alleviate the burdens of mental and neurological disorders. His goal is to enable individuals to engage meaningfully with their communities without the constraints of their symptoms; the focus is particularly on treating depressive and anxiety disorders to restore normalcy and joy to their lives.

The research, divided into three phases of preparation, treatment, and analysis, is utilizing advanced techniques like fNIRS (functional near-infrared spectroscopy), EEG (electroencephalography), and cognitive testing. Yash’s extensive lab experience and Dr. Verma’s expertise aim to enhance treatment strategies for severe urban mental health crises.

Uriel Halbreich

Dr. Uriel Halbreich has been professor of psychiatry and director of bio-behavioral research at the School of Medicine and Biomedical Sciences of the University at Buffalo (UB) since 1985. He has served as president of three professional organizations: the International Society of Psychoneuroendocrinology (ISPNE); Hormones, Brain, and Neuropsychopharmacology (HBN); and the International Association of Women`s Mental Health (IAWMH, of which he is the founding president). He has also chaired educational committees of the International College of Neuropsychopharmacology (CINP), the Association of Medicine and Psychiatry (AMP), and the World Psychiatric Association (WPA) Section on Interdisciplinary Collaboration. Under the aegis of the CINP and WPA, he has conducted over 40 educational workshops in Europe, Asia, Africa, and South America.

Dr. Halbreich has also served as a visiting professor in Harvard University, which was followed by a 12-year stint with the same university as an executive consultant. He was also a visiting professor in Al-Quds University in Palestine and a teaching professor in the University of Pisa, Italy. He is also a recipient of US NIH grants and contracts as well as of over 50 grants and contracts from pharmaceutical companies. He has published 14 books and over 400 scientific articles and chapters. He is currently the editor-in-chief of the open-access journal, Academia Mental Health and Well-Being.

Dr. Halbreich’s current scientific interests are: interdisciplinary integrative comprehensive well-being with an emphasis on culturally sensitive and person-centered stress and resilience; neuropsychoparmacology; and biomarkers for affective disorders.

The UN states that three of the world’s largest metropolitan areas are in India – Delhi, Mumbai, and Kolkata. Urbanization in India is having an accelerated adverse impact on multiple aspects of well-being and health. Dr. Halbreich’s Fulbright-Nehru project is identifying the vulnerable populations in these megacities and locating the gaps in services involving bio-social interventions. This is being carried out by conducting culturally sensitive workshops on bio-social-economic interventions with mental health and primary care providers as well as with policymakers and the interested public. The expected results are enhanced awareness about the multiple aspects of well-being and the planting of seeds for sustainable bio-social services